US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia

Clinical trial NCT04103879 · COMPLETED

Trial details

NCT number: NCT04103879
Sponsor: ExCellThera inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

High Risk Hematological Malignancy Cord Blood Transplant

Start date: 2020-11-13
Primary completion: 2026-02-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.